Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 AUD | 0.00% | -2.27% | +13.16% |
Mar. 18 | Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX All Ordinaries Index | CI |
Feb. 27 | Botanix Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 2.75M 1.8M | Sales 2023 | 3.77M 2.46M | Capitalization | 171M 111M |
---|---|---|---|---|---|
Net income 2022 | -13M -8.49M | Net income 2023 | -9M -5.88M | EV / Sales 2022 | 17.5 x |
Net cash position 2022 | 7.16M 4.68M | Net cash position 2023 | 10.25M 6.69M | EV / Sales 2023 | 42.5 x |
P/E ratio 2022 |
-4.21
x | P/E ratio 2023 |
-16.4
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.28% |
1 week | -2.27% | ||
Current month | -4.44% | ||
1 month | +7.50% | ||
3 months | +30.30% | ||
6 months | +72.00% | ||
Current year | +13.16% |
Managers | Title | Age | Since |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 19-04-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
Chief Tech/Sci/R&D Officer | 68 | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 19-02-20 |
Henry Bosch
BRD | Director/Board Member | - | 16-06-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.215 | 0.00% | 1,530,244 |
24-04-23 | 0.215 | -2.27% | 2,173,258 |
24-04-22 | 0.22 | -2.22% | 1,501,920 |
24-04-19 | 0.225 | 0.00% | 2,434,185 |
24-04-18 | 0.225 | +2.27% | 1,589,306 |
Delayed Quote Australian S.E., April 24, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+13.16% | 220M | |
+4.16% | 70.78B | |
+10.72% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+20.08% | 2.55B | |
-28.33% | 2.24B | |
-24.15% | 2.26B | |
+6.23% | 1.92B |
- Stock Market
- Equities
- BOT Stock